Founded through the merger of INC Research and inVentiv Health, Syneos Health® is a unique, fully integrated contract research organization (CRO) that provides end-to-end clinical and commercial solutions. The company's core mission is to accelerate the delivery of biopharmaceutical therapies to market, improving patient outcomes globally. Syneos Health offers a comprehensive range of services, including clinical development, bioanalytical services, and commercialization strategies, focusing on the biopharmaceutical and healthcare sectors.
Notable affiliated individuals include industry leaders from both legacy companies, contributing extensive expertise in clinical trials and commercial strategies. Syneos Health has garnered significant investment from prominent venture capital firms and institutional investors. Key achievements include successful partnerships with leading biopharmaceutical companies and a robust portfolio of completed clinical trials. The overall impact of Syneos Health is evident in its ability to streamline the drug development process, ultimately enhancing the availability of innovative therapies for patients worldwide.